| Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action-a short report SS Ansari, N Akgün, MR Berger Cellular oncology 40, 89-96, 2017 | 12 | 2017 |
| Avanafil as a novel therapeutic agent against LPS-induced acute lung injury via increasing CGMP to downregulate the TLR4-NF-κB-NLRP3 inflammasome signaling pathway P Aydin, ZBA Magden, SK Uzuncakmak, H Halici, N Akgun, AS Mendil, ... Lung 200 (5), 561-572, 2022 | 10 | 2022 |
| Sepsis: Immunopathology, Immunotherapies, and Future Perspectives. T Tavaci, N Akgun Eurasian Journal of Medicine 54, 2022 | 2 | 2022 |
| Effect of RhoB depletion on the sensitivity of nonsmall-cell lung cancer (NSCLC) cells to Akt inhibition in vitro N Akgun, Z Halici BRITISH JOURNAL OF PHARMACOLOGY 180 (4), 483-484, 2023 | | 2023 |
| Effect of Tocilizumab on Acinetobacter baumannii Lung Infection in an Immunosuppressed Rat Model D Celebi, Z Halici, O Celebi, N Akgun, I CINAR, I HALICI, KT CINISLI, ... Kafkas Üniversitesi Veteriner Fakültesi Dergisi 28 (1), 2022 | | 2022 |
| The tumor suppressor RhoB is upregulated in response to the alkylphosphocholine erufosine in oral squamous cell carcinoma S Ansari, N Akguen, MR Berger INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36, S52-S52, 2015 | | 2015 |
